Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Luis Fernando Valladales-Restrepo, María Camila Oyuela-Gutiérrez, Ana Camila Delgado-Araujo, Juliana Calvo-Salazar, Daniel Osorio-Bustamante, Cesar Eduardo Lerma-Barco & Jorge Enrique Machado-Alba. (2023) Adherence to Inhalation Devices in Patients with Chronic Obstructive Pulmonary Disease. Patient Preference and Adherence 17, pages 3233-3244.
Read now
Read now
Piotr Damiański, Grzegorz Kardas, Michał Panek, Piotr Kuna & Maciej Kupczyk. (2022) Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions. Expert Opinion on Drug Safety 21:4, pages 499-515.
Read now
Read now
Anne Tschacher, Cordula Cadus, Sebastian Schildge, Jens Peter Diedrich, Prashant N. Chhajed, Anne B. Leuppi-Taegtmeyer & Jörg Daniel Leuppi. (2021) Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland. Current Medical Research and Opinion 37:11, pages 2019-2033.
Read now
Read now
Katharina Ruessel, Eva Luecke & Jens Schreiber. (2020) Inhaler Devices in a Geriatric Patient Population: A Prospective Cross-Sectional Study on Patient Preferences. Patient Preference and Adherence 14, pages 1811-1822.
Read now
Read now
Kaho Akimoto, Kuniaki Hirai, Tomohiro Matsunaga, Keisuke Kaneko, Hatsuko Mikuni, Tomoko Kawahara, Tomoki Uno, Akiko Fujiwara, Yoshito Miyata, Shin Ohta, Tetsuya Homma, Hideki Inoue, Fumihiro Yamaguchi, Sojiro Kusumoto, Shintaro Suzuki, Akihiko Tanaka & Hironori Sagara. (2020) The Relationship Between the “Adherence Starts with Knowledge-20” Questionnaire and Clinical Factors in Patients with COPD: A Multi-Center, Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3201-3211.
Read now
Read now
Omar S Usmani. (2019) Choosing the right inhaler for your asthma or COPD patient. Therapeutics and Clinical Risk Management 15, pages 461-472.
Read now
Read now
Gihan Hamdy Elsisi, João Carapinha, Wagdy Amin, Ehab Thabet, Safaa Elafify, Mohamad Amin & Ashraf Hatem. (2019) A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt. Journal of Medical Economics 22:10, pages 1047-1054.
Read now
Read now
José Luis López-Campos, Esther Quintana Gallego & Laura Carrasco Hernández. (2019) Status of and strategies for improving adherence to COPD treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1503-1515.
Read now
Read now
Todd P. Gilmer, Bartolome R. Celli, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Maryam Navaie. (2019) Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease*. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 140-151.
Read now
Read now
Antonio Molino, Giovanna Calabrese & Mauro Maniscalco. (2018) Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol. Patient Preference and Adherence 12, pages 993-1001.
Read now
Read now
Alpesh N Amin, Vaidyanathan Ganapathy, Adam Roughley & Mark Small. (2017) Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease. Patient Preference and Adherence 11, pages 1205-1212.
Read now
Read now
Jaco Voorham, Bernard Vrijens, Job FM van Boven, Dermot Ryan, Marc Miravitlles, Lisa M Law & David B Price. (2017) Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study. Pragmatic and Observational Research 8, pages 31-41.
Read now
Read now
Josep Darbà, Gabriela Ramírez, Juan L García-Rivero, Sagrario Mayoralas-Alises, José Francisco Pascual, Albert Roger, Diego Vargas & Adi Bijedic. (2016) A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions. ClinicoEconomics and Outcomes Research 8, pages 435-444.
Read now
Read now
Eleftherios Zervas, Konstantinos Samitas & Mina Gaga. (2016) Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1845-1855.
Read now
Read now
Articles from other publishers (27)
Sorin Bivolaru & Ancuţa Constantin. (2023) The Impact of Technical Skills and Education on Exacerbations, Adherence to Treatment and the Choice of Inhaler Device in Patients with COPD. Internal Medicine 20:1, pages 27-41.
Crossref
Crossref
Tereza Hendrychova, Michal Svoboda, Josef Maly, Jiri Vlcek, Eva Zimcikova, Tomas Dvorak, Jaromir Zatloukal, Eva Volakova, Marek Plutinsky, Kristian Brat, Patrice Popelkova, Michal Kopecky, Barbora Novotna & Vladimir Koblizek. (2022) Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population. Frontiers in Pharmacology 13.
Crossref
Crossref
Aizhamal Tabyshova, Talant Sooronbaev, Azamat Akylbekov, Maamed Mademilov, Aida Isakova, Aidai Erkinbaeva, Kamila Magdieva, Niels H. Chavannes, Maarten J. Postma & Job F. M. van Boven. (2022) Medication availability and economic barriers to adherence in asthma and COPD patients in low-resource settings. npj Primary Care Respiratory Medicine 32:1.
Crossref
Crossref
Stefanie C. Nigro & Diana M. Sobieraj. (2021) Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease. Annals of Pharmacotherapy 56:5, pages 582-591.
Crossref
Crossref
Constança Monteiro, Tiago Maricoto, Filipe Prazeres, Pedro Augusto Simões & José Augusto Simões. (2022) Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature. Respiratory Medicine 191, pages 106724.
Crossref
Crossref
Paschalis Steiropoulos, Stavros Tryfon, Christos Kyriakopoulos, Konstantinos Bartziokas & Konstantinos Kostikas. (2021) Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study. Journal of Personalized Medicine 11:11, pages 1159.
Crossref
Crossref
Darsuh Attar-Zadeh, Harriet Lewis & Martina Orlovic. (2021) Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England. Journal of Health Economics and Outcomes Research 8:2, pages 46-54.
Crossref
Crossref
Darsuh Attar-Zadeh, Harriet Lewis & Martina Orlovic. (2021) Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England. Journal of Health Economics and Outcomes Research 8:2.
Crossref
Crossref
Christine Jenkins. (2021) Differences Between Men and Women with Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 42:3, pages 443-456.
Crossref
Crossref
Omar S. Usmani, Anthony J. Hickey, Deniz Guranlioglu, Kacey Rawson, Neda Stjepanovic, Shahid Siddiqui & Rajiv Dhand. (2021) The Impact of Inhaler Device Regimen in Patients with Asthma or COPD. The Journal of Allergy and Clinical Immunology: In Practice 9:8, pages 3033-3040.e1.
Crossref
Crossref
Jens Schreiber, Tina Sonnenburg & Eva Luecke. (2020) Inhaler devices in asthma and COPD patients – a prospective cross-sectional study on inhaler preferences and error rates. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Sarah Serhal, Bandana Saini, Sinthia Bosnic-Anticevich, Ines Krass, Frances Wilson & Carol Armour. (2020) Medication Adherence in a Community Population with Uncontrolled Asthma. Pharmacy 8:4, pages 183.
Crossref
Crossref
Todor A. Popov, Gianni Passalacqua, Sandra N. González-Díaz, Davor Plavec, Fulvio Braido, Jose-Luis García-Abujeta, Lawrence Dubuske, Philip Rouadi, Mário Morais-Almeida, Sergio Bonini, Lei Cheng & Ignacio J. Ansotegui. (2020) Medical devices in allergy practice. World Allergy Organization Journal 13:10, pages 100466.
Crossref
Crossref
Tareen Sanaullah, Shereen Khan, Aria Masoom, Zahir K Mandokhail, Aisha Sadiqa & Muhammad Irfan Malik. (2020) Inhaler Use Technique in Chronic Obstructive Pulmonary Disease Patients: Errors, Practices and Barriers. Cureus.
Crossref
Crossref
Wijdan H. Ramadan, Aline Sarkis, Sandrine Sarine Aderian & Aline Milane. (2020) Asthma and COPD Patients’ Perception of Appropriate Metered-Dose Inhaler Technique. Dose-Response 18:2, pages 155932582091783.
Crossref
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
Crossref
Anna-Maria Ciciliani, Peter Langguth & Herbert Wachtel. (2019) Handling forces for the use of different inhaler devices. International Journal of Pharmaceutics 560, pages 315-321.
Crossref
Crossref
Magda Vytrisalova, Tereza Hendrychova, Tereza Touskova, Eva Zimcikova, Jiri Vlcek, Libor Nevoranek, Michal Svoboda, Karel Hejduk, Kristian Brat, Marek Plutinsky, Barbora Novotna, Pavlina Musilova, Matej Cernohorsky & Vladimir Koblizek. (2019) Breathing Out Completely Before Inhalation: The Most Problematic Step in Application Technique in Patients With Non-Mild Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Federico Lavorini, Christer Janson, Fulvio Braido, Georgios Stratelis & Anders Løkke. (2019) What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape. Therapeutic Advances in Respiratory Disease 13, pages 175346661988453.
Crossref
Crossref
Pablo Altman, Luis Wehbe, Juergen Dederichs, Tadhg Guerin, Brian Ament, Miguel Cardenas Moronta, Andrea Valeria Pino & Pankaj Goyal. (2018) Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial. BMC Pulmonary Medicine 18:1.
Crossref
Crossref
Marc Miravitlles, Juan José Soler-Cataluña, Bernardino Alcázar, José Luis Viejo & Francisco García-Río. (2018) Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus. Pulmonary Pharmacology & Therapeutics 48, pages 97-103.
Crossref
Crossref
Wijdan H Ramadan & Aline T Sarkis. (2017) Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study. Chronic Respiratory Disease 14:3, pages 309-320.
Crossref
Crossref
A. Lewis, S. Torvinen, P.N.R. Dekhuijzen, H. Chrystyn, A. Melani, Y. Zöllner, K. Kolbe, A.T. Watson, M. Blackney & A. Plich. (2017) Budesonide + formoterol delivered via Spiromax ® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler ®. Respiratory Medicine 129, pages 179-188.
Crossref
Crossref
Imran Sulaiman, Breda Cushen, Garrett Greene, Jansen Seheult, Dexter Seow, Fiona Rawat, Elaine MacHale, Matshediso Mokoka, Catherine Nora Moran, Aoife Sartini Bhreathnach, Philippa MacHale, Shahed Tappuni, Brenda Deering, Mandy Jackson, Hannah McCarthy, Lisa Mellon, Frank Doyle, Fiona Boland, Richard B. Reilly & Richard W. Costello. (2017) Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 195:10, pages 1333-1343.
Crossref
Crossref
Deepa Raghavan, Anita Varkey & Thaddeus Bartter. (2017) Chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 23:2, pages 117-123.
Crossref
Crossref
Paola Rogliani, Luigino Calzetta, Angelo Coppola, Francesco Cavalli, Josuel Ora, Ermanno Puxeddu, Maria Gabriella Matera & Mario Cazzola. (2017) Optimizing drug delivery in COPD: The role of inhaler devices. Respiratory Medicine 124, pages 6-14.
Crossref
Crossref
Bruce G. Bender, Ramon A. Hernandez Vecino, Kevin McGrath & Spencer Jones. (2016) Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy. The Journal of Allergy and Clinical Immunology: In Practice 4:5, pages 884-889.
Crossref
Crossref